Moreover, in the context of immune thrombocytopenia (ITP), researchers have developed a novel chimeric autoantibody receptor targeting glycoprotein (GP) Ibα (GP Ibα-CAAR T cells). This evidence concerns the gene ART4 and autoimmune thrombocytopenic purpura.